Medroxyprogesterone 17-acetate, Progesterone receptor agonist (ab142633)
Key features and details
- Angiostatic steroid. Potent progesterone receptor agonist
- CAS Number: 71-58-9
- Purity: > 99%
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Medroxyprogesterone 17-acetate, Progesterone receptor agonist -
Description
Angiostatic steroid. Potent progesterone receptor agonist -
Purity
> 99% -
CAS Number
71-58-9 -
Chemical structure
Properties
-
Chemical name
[(6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate -
Molecular weight
386.52 -
Molecular formula
C24H34O4 -
PubChem identifier
6279 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C -
Source
Synthetic
-
Research areas
- Epigenetics and Nuclear Signaling
- Nuclear Signaling Pathways
- Nuclear Receptors
- Orphan Nuclear Receptors
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Nucleotide metabolism
- Molecular processes
- Mitochondrial transcription
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (1)
ab142633 has been referenced in 1 publication.
- Wei L et al. Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell Death Discov 9:30 (2023). PubMed: 36693834